content top

PET for Assessing Cancer Treatment Respo...

PET for Assessing Cancer Treatment Response.
Time: 08:30 AM – 10:00 AM Author: Neeta Pandit-Taskar, MD, and, Richard L. Wahl, MD Code: RC811 Objective: This session discusses important methods used for evaluation of treatment response. It highlights the important examination findings on PET CT using FDG PET and other novel tracers to understand how to avoid potential pitfalls. Attendees will learn how to interpret relevant...

Imaging Modalities for Molecular Imaging

Imaging Modalities for Molecular Imaging
Time: 08:30 AM – 10:00 AM Author: John C. Gore, PhD Code: MI41 Objective: This session has three sections. The first is PET, which provides an introduction to positron emission tomography (PET), its preclinical and clinical uses. This section compares PET to other molecular imaging modalities with respect to sensitivity for detecting molecular phenomena, ability to be translated...

Case-based Review of Nuclear Medicine: P...

Case-based Review of Nuclear Medicine: PET/CT Workshop—Head and Neck Cancers
Time: 08:30 AM – 10:00 AM Author: Michael M. Graham MD, PhD, and Michael M. Graham, MD, PhD Code: CC31 Objective: This session recognizes the appearance of normal structures of the head and neck in FDG PET CT studies. It also recognizes the appearance and location of common tumors of the head and neck in FDG PET CT studies. Attendees will learn the nodal stations in the head and...

Improving Your PET Practice.

Improving Your PET Practice.
Time: 08:30 AM – 10:00 AM Author: Harry Agress and Paul David Shreve Code: RC211 Objective: Attendees will learn more about the common pitfalls of PET/CT image interpretation in a busy radiology practice and solutions for interpretive errors and oversights. This session discusses key significance of thoroughly evaluating both the PET (metabolic) and CT (anatomic) components and...

Musculoskeletal Imaging in the Era of Mo...

Musculoskeletal Imaging in the Era of Molecular Medicine.
Time: 2:00 PM- 3:30 PM Author: Homer Aquino Macapinlac, Philipp Mayer-Kuckuk, and Sandip Biswal Code: RC117 Objective: This session includes three sections; the first one is Clinical Radionuclide Imaging Agents for Musculoskeletal Malignancies, which reviews the clinical utility of Tc-99m MDP planar and SPECT/CT imaging as well as F18 Fluoride PET/CT in patients with Musculoskeletal...